文献速递皮肤感染

激光治疗趾甲甲真菌病改善率的批判性综述

A critical review of improvement rates for laser therapy used to treat toenail onychomycosis.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-04-03

本文通过检索PubMed、Clinicaltrials.gov、Medline和Embase,综述激光治疗趾甲甲真菌病的改善率并与FDA批准适应症及传统治疗比较。结果显示真菌学治愈率(患者分析)平均11%,临床治愈率13%,临床改善率患者36%、甲67%,12周清晰甲生长2.6 mm。激光仅提供初步证据,医疗终点疗效未达或超过传统治疗。

要点

  • 真菌学治愈率(患者分析)平均11%,甲分析63%。
  • 临床治愈率(100%清晰甲)为13%。
  • 临床改善率患者36%、甲67%,12周清晰甲生长2.6 mm。

核心结论

  • 激光治疗趾甲甲真菌病提供临床改善和清晰甲生长的初步证据,符合FDA美学终点,但医疗终点疗效未达或超过传统治疗。

研究设计与样本

  • 文献综述,检索PubMed、Clinicaltrials.gov、Medline和Embase,纳入至少报告完全治愈、真菌学治愈、临床改善或临床治愈之一的RCT、非随机、非对照和回顾性研究。

主要发现

  • 真菌学治愈(培养和镜检阴性)在两项以患者为分析单位的研究中平均率为11%,在三项以甲为分析单位的研究中升至63%。
  • 临床治愈(100%清晰甲)在六项以甲为分析单位的研究中率为13%,在两项以患者为分析单位的研究中率为13%。
  • 临床改善(任意时间点)在五项研究中患者率为36%,在九项研究中甲率为67%。
  • 12周时清晰甲生长和/或甲板/甲床清除平均为2.6 mm。

关键数值与推荐

  • 真菌学治愈率:患者分析平均11%,甲分析63%。
  • 临床治愈率:甲分析13%,患者分析13%。
  • 临床改善率:患者36%,甲67%。
  • 12周清晰甲生长平均2.6 mm。

临床怎么用

  • 激光可作为美学终点改善清晰甲,但不应替代传统口服或外用抗真菌治疗。

局限性

  • 激光研究仅提供初步证据,未报告医疗终点疗效等同或超过传统治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Onychomycosis is a nail infection that is primary caused by dermatophytes. Alternative treatments are needed as current therapies (oral and topical antifungals) have limited effectiveness. Lasers are currently approved by the FDA to temporarily increase the amount of clear nail in onychomycosis patients. Lasers can theoretically elicit fungicidal effects but in practice produce mixed results. This review compared laser-induced improvement rates to FDA-approved indications and traditional onychomycosis treatments. A review of the literature (PubMed, Clinicaltrials.gov, Medline and Embase) was used to locate articles for this review. RCTs, non-randomized, uncontrolled and retrospective studies that included at least one of the following measures were eligible; complete cure, mycological cure, clinical improvement and clinical cure. Mycological cure (negative culture and negative microscopy) was evaluated in two studies using patients as the unit of analysis with an average rate of 11%, increasing to 63% when nails were used as the unit of analysis (three studies). Clinical cure (100% clear nail) was evaluated in six studies with a rate of 13% using nails as the unit of analysis and 13% when patients were used as the unit of analysis (two studies). Clinical improvement (at any time point) was found in 36% of patients (five studies) and 67% of nails (nine studies). Nail clarity as measured by clear nail growth and/or nail plate/bed clearance at 12 weeks was found to be 2.6 mm across onychomycotic nails. Laser studies, to date, provide preliminary evidence of clinical improvement and clear nail growth in toenail onychomycosis, consistent with the FDA clearance for aesthetic endpoints. Laser studies however do not provide efficacy rates for medical endpoints that equate or exceed those found with traditional therapies (oral and topical treatments).

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Gupta AK, Versteeg SG. A critical review of improvement rates for laser therapy used to treat toenail onychomycosis. J Eur Acad Dermatol Venereol. 2017. PMID: 28294418. doi:10.1111/jdv.14212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。